Insurance Pre-approval and Medical Visa for GBM in India

If you or someone you care for has glioblastoma (GBM) and is considering treatment in India, two administrative processes determine whether you arrive ready to start or face delays that push your first appointment back by weeks. The first is insurance pre-approval, the written agreement from your insurer that funds the treatment before you travel. The second is the Indian Medical Visa. Both take longer than most families expect. Starting them in parallel, roughly six weeks before your intended travel date, gives you the best chance of arriving with funding confirmed and entry papers in hand.

This guide breaks each process into concrete steps, covers the documents hospitals and insurers need, and flags the country-specific differences that most general guides miss. For a broader view of what treatment in India looks like and what you will likely pay, see Glioblastoma Treatment in India: Costs, Visa and What to Expect.

What does insurance pre-approval actually mean?

Pre-approval, also called pre-authorization, is a written agreement from your insurer confirming they will fund a specific treatment at a specific facility, issued before you travel. Without it, most international health insurers will reject a post-treatment claim outright, regardless of what your policy states. Many policies make this explicit: submitting a claim without a pre-approval letter on file results in automatic rejection even when the procedure is listed as a covered benefit. A verbal confirmation from a call-center agent is not binding.

GBM treatment is not a single procedure. The standard initial course includes surgery, followed by concurrent radiation and chemotherapy, sometimes with Tumor Treating Fields added later. Each component may need a separate authorization. A review on traveling with cancer shows that coordinating medical documentation and financial coverage before travel is one of the most common points where cross-border care is disrupted. Ask your insurer specifically whether surgery, radiation, and chemotherapy are each covered, and whether each phase requires its own approval letter.

How do you get insurance pre-approval for GBM treatment in India?

1. Confirm your policy covers planned treatment abroad. Call your insurer and ask explicitly. Standard travel insurance almost never covers planned or elective medical procedures outside your home country. You need an international health insurance policy or a policy with a specific medical treatment abroad benefit.
2. Get a written diagnosis summary from your current oncologist. This should include the WHO grade, molecular markers such as MGMT methylation status and IDH status, imaging findings, and the proposed treatment plan. One clinic appointment is usually enough to generate this on official letterhead.
3. Contact the Indian hospital's international patient desk. Ask for a written treatment proposal, an itemized cost estimate, and the hospital's accreditation certificate. Look for NABH (National Accreditation Board for Hospitals) or JCI (Joint Commission International) accreditation - these are the two standards that most international insurers recognize.
4. Submit your pre-approval request in writing. Include your diagnosis summary, the proposed treatment plan, the itemized hospital estimate, the hospital's accreditation details, and any relevant imaging reports. Send by email and confirm receipt.
5. Follow up every five business days. International pre-authorization teams are often slower than domestic claims desks. Written follow-ups keep your file active and create a paper trail if you need to escalate.
6. Get the approval document before booking flights. The letter must name the procedure, the facility, the approved amount, and the validity period.
7. Ask for a named case manager or third-party administrator (TPA) at the Indian hospital. A TPA acts as a local representative for your insurer, handling billing directly with the hospital and reducing the risk of post-treatment disputes.

Which insurance models are most common for this route?

Patients traveling to India for GBM treatment typically fall into one of three situations:

• GCC government or employer insurance. Many patients from UAE, Saudi Arabia, Oman, and Qatar hold employer-sponsored plans that list India as an approved treatment destination and carry pre-negotiated rates with specific hospitals. Check your policy documents for a network hospital list. Confirm that your specific hospital is included before submitting the pre-approval request.
• Private international health insurance. Plans from international insurers typically cover planned inpatient treatment at JCI or NABH-accredited facilities. The pre-authorization process is usually described in your policy handbook. For a complex oncology case, processing commonly takes two to four weeks once the insurer has received all documents.
• Self-pay with reimbursement intent. Some families pay out-of-pocket and submit a reimbursement claim on return. This route carries significant financial risk. Before you travel, get written confirmation from your insurer of the reimbursement process, the maximum reimbursable amount, and the submission deadline. The Brain Tumour Charity notes that travel insurance with a brain tumor diagnosis can be costly or difficult to obtain, and that patients must disclose their diagnosis in full to avoid policy voidance.

If you are still deciding which hospital to approach and want an independent review of your case before committing to a facility, you can arrange a remote second opinion through Art of Healing Cancer. Their team works with patients from GCC, Africa, and South Asia and can help you understand which treatment pathway fits your molecular profile and situation.

What documents does the Indian hospital need from you?

Before the hospital can issue a treatment proposal for your insurer or an invitation letter for the visa, their specialists need to review your case. Prepare a single organized digital file containing the following:

• Brain MRI scans in DICOM format on a CD or USB - hospitals need the original image files to plan surgery or radiation, not printed films or photos
• The full neuropathology report from biopsy or surgery, including molecular markers
• Operative reports if surgery has already been performed
• A treatment summary showing chemotherapy drugs and doses received to date, and total radiation dose if applicable
• Current medications list

Sending incomplete records is the most common reason for delays at this stage. For guidance on which documents matter most when approaching a specialist team and what they assess, see Evaluating Glioblastoma Treatment Centers in India: What to Assess.

How to apply for an Indian Medical Visa

The Indian Medical Visa is a separate category from tourist or business visas, designed specifically for patients traveling to India for treatment. Up to two family members may apply at the same time for an e-Medical Attendant Visa. The standard Indian e-Medical Visa permits a stay of up to 60 days with triple entry. Stays beyond 60 days require a visit to the Foreigners Regional Registration Office (FRRO) in India for an extension.

GBM treatment from surgery through the full concurrent chemoradiation phase typically spans twelve to fourteen weeks. Many international patients manage this by structuring two entries: the first for surgery and post-operative recovery, the second for radiation and chemotherapy. Some patients arrange local radiation near home and return to India only for the surgical phase. Discuss the sequence with the hospital when you request the treatment proposal.

The core documents for the Medical Visa application are:

• A valid passport with at least six months of remaining validity from the date of arrival and at least two blank pages
• A hospital invitation letter on official letterhead, signed and stamped by the treating specialist, stating the diagnosis, proposed treatment, expected treatment dates, and the names and passport details of any attendants applying at the same time
• Medical records confirming the diagnosis and the clinical need for treatment in India
• Proof of sufficient funds to cover the treatment and stay
• A recent passport-format photograph meeting the official specifications for your country of application

The hospital's international patient desk generates the invitation letter as part of standard intake, once specialists have reviewed your records. Apply at least three to four weeks before your intended travel date to allow time for corrections if any documents are rejected.

Country-specific notes for the visa application

The e-Medical Visa application is broadly consistent across source countries, but the submission channel differs:

• UAE and GCC countries: Apply online through the official Indian Visa Online portal. Processing typically takes three to seven working days. Urgent applications can also be submitted in person at the Indian Mission.
• Nigeria: The Indian hospital must email the invitation letter directly to the High Commission of India in Abuja before you submit the visa application. Applicants then attach a printout of the invitation letter and the forwarding email to the physical application form. See the High Commission of India, Abuja for the current submission address and contact details.
• Kenya and East Africa: The hospital invitation letter should be sent to the consular email at the High Commission of India in Nairobi before applying. For the current checklist and contact details, see the High Commission of India, Nairobi.
• Bangladesh, Nepal, and Sri Lanka: The Indian High Commissions in these countries process medical visa applications at high volume. The online portal is typically sufficient; in-person appointments are rarely required for straightforward medical visa cases.

Running both tracks at the same time

The insurance and visa processes are independent, but they rely on many of the same documents, particularly the hospital invitation letter, the treatment plan, and your imaging and pathology records. Keeping your records in one organized digital file saves time when submitting to both your insurer and the visa portal. A practical sequence:

1. Gather your medical records and imaging from your current hospital.
2. Send them to your chosen Indian hospital and request a treatment proposal and invitation letter simultaneously.
3. When the hospital sends both documents, submit them to your insurer for pre-approval and to the Indian visa portal for the MED visa at the same time.

Running these steps in parallel rather than sequentially can save two to three weeks, which matters when treatment needs to start quickly. If you are also considering a remote second opinion before choosing a facility, doing that first sharpens your hospital selection and makes the subsequent paperwork more targeted. See Remote Second Opinion for Glioblastoma: How to Prepare Your Materials and What to Expect for a practical guide to organizing your records for a virtual review.

When you are ready to take the next step, you can upload your MRI and reports through the Glioblastoma Center patient journey form to request a remote case review and discuss treatment options in India.

When to talk to your doctor

Confirm the proposed treatment plan with your current oncologist or a second-opinion specialist before submitting any pre-approval request. A plan that your treating doctor has reviewed and endorsed is more likely to be approved by your insurer. If your insurer requires a formal referral letter, your current physician is the appropriate source for that document.

This article is for general information and is not a substitute for medical advice. Always consult your oncologist or care team about your specific situation.